Artificial cell membrane binding thrombin constructs drive in situ fibrin hydrogel formation.

ABSTRACT: Cell membrane re-engineering is emerging as a powerful tool for the development of next generation cell therapies, as it allows the user to augment therapeutic cells to provide additional functionalities, such as homing, adhesion or hypoxia resistance. To date, however, there are few examples where the plasma membrane is re-engineered to display active enzymes that promote extracellular matrix protein assembly. Here, we report on a self-contained matrix-forming system where the membrane of human mesenchymal stem cells is modified to display a novel thrombin construct, giving rise to spontaneous fibrin hydrogel nucleation and growth at near human plasma concentrations of fibrinogen. The cell membrane modification process is realised through the synthesis of a membrane-binding supercationic

SUBMITTER: Deller RC 

PROVIDER: S-EPMC6478844 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature